LEADER 02063nam 2200409 450 001 9910814263603321 005 20191030060418.0 010 $a92-4-069881-7 035 $a(CKB)4100000009444173 035 $a(MiAaPQ)EBC5910088 035 $a(EXLCZ)994100000009444173 100 $a20191030d2019 uy 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aFirst WHO model list of essential in vitro diagnostics 210 1$aGeneva :$cWorld Health Organization,$d[2019] 210 4$dİ2019 215 $a1 online resource (73 pages) 225 1 $aWHO technical report series ;$v1017 311 $a92-4-121026-5 320 $aIncludes bibliographical references. 330 $aIn May 2018 the World Health Organization (WHO) published the first ever Model List of Essential In Vitro Diagnostics (EDL). The objective of the list is to help countries develop or update their national essential diagnostics lists raise awareness and political will guide procurement and regulation policies and improve access to the most important in vitro diagnostics that all countries need to make available to their populations particularly in low-resourced countries. It will also contribute towards health systems strengthening and realizing universal health coverage. The 1st EDL list includes 62 test categories divided into two levels and two categories: - Level I: primary care settings where no or minimal laboratory services are available - Level II: facilities with laboratories - Category a: general IVDs - Category b: disease-specific IVDs 410 0$aTechnical report series (World Health Organization) ;$v1017. 606 $aDiagnosis 615 0$aDiagnosis. 676 $a616.075 700 $aOrganization$b World Health$0819556 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910814263603321 996 $aFirst WHO model list of essential in vitro diagnostics$93984435 997 $aUNINA